SR-2: Onset of second cancer after proton beam therapy “proton”, “child OR children OR childhood OR pediatric OR pediatrics”, “secondary OR radiation-induced”, and “cancer OR tumor OR neoplasm OR malignancy” 158 5 [4], [9], [16], [26], [27] Based on in silico analysis, PB...
Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus. BACKGROUNDTreatment modalities for patients with hepatocellular carcinoma (HCC) who have portal vein tumor thrombus (PVTT) are limited and controversial; f... M Hata,K Tokuuye,S Sugahara,... - 《Cancer》 被引量:...
A comparative effectiveness review of proton beam therapy by the Veteran's Health Administration (2015) reached the following conclusions: "For the cancer sites and types reviewed by the ESP report, there are no reliable data from long-term randomized trials on survival, quality of life, or func...
The treatment effectiveness of cancer is closely related to advances in radiation therapy technology [18]. Protons, as particles, are different from photons such as X-rays and gamma rays; they continuously slow down as they change in depth. This process of dose deposition creates the characteristi...
Reduction in quality of life due to retardation of growth and development and secondary cancer are also significant problems in pediatric patients.2, 3 Particle therapy, including proton beam therapy (PBT), has unique physical properties that allow for the reduction or elimination of unnecessary ...
Proton therapy is an advanced cancer treatment technique that delivers highly targeted dose to the tumour while sparing surrounding normal tissue, enabled by the finite range of the proton beam. This precision targeting, however, is compromised by tumour motion or anatomical changes throughout a cours...
Ions provide a more advantageous dose distribution than photons for external beam radiotherapy, due to their so-called inverse depth dose deposition and, in particular a characteristic dose maximum at their end-of-range (Bragg peak). The favorable physical interaction properties enable selective treatme...
With an increasing number of proton centers capable of delivering pencil beam scanning (PBS), understanding the dosimetric differences in PBS compared to passively scattered proton therapy (PSPT) for pancreatic cancer is of interest.Optimized PBS plans were retrospectively generated for 11 patients with...
Conclusions Proton beam radiotherapy affords excellent dosimetric parameters and low toxicity in patients with esophageal cancer treated with curative intent. Prospective trials are underway investigating the comparative benefit of proton-based therapy.
Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients. Radiother Oncol. 2013;109(1):100–6. 4. Sejpal S, Komaki R, Tsao A, Chang JY, Liao Z, Wei X, et al. Early findings on toxicity of proton beam therapy with concurrent ...